Novo Nordisk A/S (NONOF)
44.64
+0.18
(+0.41%)
USD |
OTCM |
May 19, 16:00
Novo Nordisk Market Cap : 197.85B for May 19, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Eli Lilly & Co. | 910.83B |
| ALK-Abello A/S | 8.617B |
| H. Lundbeck A/S | 7.104B |
| Dr. Reddy's Laboratories Ltd. | 11.20B |
| AstraZeneca PLC | 286.35B |
Market Cap Related Metrics
| PE Ratio | 10.48 |
| PS Ratio | 3.900 |
| PEG Ratio | 0.40 |
| Price to Book Value | 6.319 |
| Price to Free Cash Flow | 97.81 |
| Price | 44.64 |
| Earnings Yield | 9.54% |
| PEGY Ratio | 0.3464 |
| Operating PE Ratio | 8.581 |
| Normalized PE Ratio | 10.48 |